GJA1 and epilepsy: In this line, tonabersat, a compound active against neurogenic inflammation proposed in the treatment for epilepsy and as a prophylactic treatment for migraine with aura, two frequent comorbidities, prevents inflammatory damage in the CNS by blocking Cx43 HCs (Kim et al., 2017).